Zoll Medical Corp. (ZOLL) Tops Q3 EPS by 7c; Guides FY11 EPS Growth
Tweet
Share
E-mailGet Alerts ZOLL Hot Sheet
Join SI Premium – FREE
Zoll Medical Corp. (NASDAQ: ZOLL) reported Q3 EPS of $0.42, $0.07 better than the analyst estimate of $0.35. Revenue for the quarter came in at $136.2 million versus the consensus estimate of $129.97 million.
Sees FY11 EPS in mi-$1.30's. Consensus sees EPS of $1.27.
Sees FY11 EPS in mi-$1.30's. Consensus sees EPS of $1.27.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Dare Bioscience (DARE) Tops Q2 EPS by 11c
- Jernigan Capital (JCAP) Tops Q2 EPS by 5c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
